What is LOPJLB’s current signal on TVRD?

LOPJLB’s latest quantitative signal on Tvardi Therapeutics, Inc. (TVRD) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is TVRD in?

Tvardi Therapeutics, Inc. (TVRD) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Tvardi Therapeutics, Inc. (TVRD) do?

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical…